Literature DB >> 27085483

HMGCR is up-regulated in gastric cancer and promotes the growth and migration of the cancer cells.

Li Chushi1, Wu Wei1, Xie Kangkang1, Feng Yongzeng2, Xie Ning1, Chen Xiaolei3.   

Abstract

Alteration of metabolic profile is one of the hallmarks of cancer cells. Statin, the inhibitors for synthesis of cholesterol, has shown anti-cancer effects on the gastric cancer cells. However, the functions of its target, HMGCR, in the progression of gastric cancer remain unknown. In the present study, we investigated the expression profile and the biological functions of HMGCR in gastric cancer. It was found that the expression of HMGCR was increased in gastric cancer tissues. Over-expression of HMGCR promoted the growth and migration of gastric cancer cells, while knocking down the expression of HMGCR inhibited the growth, migration and tumorigenesis of gastric cancer cells. In the further molecular mechanism study, HMGCR was shown to activate Hedgehog/Gli1 signaling and promoted the expression of Gli1 target genes. Taken together, this study demonstrated the tumor-promoting effects of HMGCR in gastric cancer and suggested HMGCR as a promising therapeutic target.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Cell growth and migration; Gastric cancer; HMGCR; Hedgehog/Gli1 signaling

Mesh:

Substances:

Year:  2016        PMID: 27085483     DOI: 10.1016/j.gene.2016.04.029

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  32 in total

Review 1.  Triggers of inflammatory myopathy: insights into pathogenesis.

Authors:  Brittany L Adler; Lisa Christopher-Stine
Journal:  Discov Med       Date:  2018-02       Impact factor: 2.970

2.  Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women.

Authors:  Joo Hyun Lim; Cheol Min Shin; Kyungdo Han; Juhwan Yoo; Eun Hyo Jin; Yoon Jin Choi; Dong Ho Lee
Journal:  Gastric Cancer       Date:  2021-09-01       Impact factor: 7.370

Review 3.  Roles of ABCA1 in cancer.

Authors:  Kun Wu; Longwei Zou; Xiaoyong Lei; Xiaoyan Yang
Journal:  Oncol Lett       Date:  2022-08-19       Impact factor: 3.111

4.  The mevalonate pathway promotes the metastasis of osteosarcoma by regulating YAP1 activity via RhoA.

Authors:  Xing Du; Yunsheng Ou; Muzi Zhang; Kai Li; Wei Huang; Dianming Jiang
Journal:  Genes Dis       Date:  2020-11-21

5.  MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy.

Authors:  Kathleen Saavedra; Karla Leal; Nicolás Saavedra; Yalena Prado; Isis Paez; Carmen G Ubilla; Gabriel Rojas; Luis A Salazar
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

Review 6.  The Role of Lipid Metabolism in Gastric Cancer.

Authors:  Meng-Ying Cui; Xing Yi; Dan-Xia Zhu; Jun Wu
Journal:  Front Oncol       Date:  2022-06-15       Impact factor: 5.738

Review 7.  Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.

Authors:  Isabella Giacomini; Federico Gianfanti; Maria Andrea Desbats; Genny Orso; Massimiliano Berretta; Tommaso Prayer-Galetti; Eugenio Ragazzi; Veronica Cocetta
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

8.  Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.

Authors:  Hanbo Yang; Qinglin Peng; Liguo Yin; Shanshan Li; Jingli Shi; Yamei Zhang; Xin Lu; Xiaoming Shu; Sigong Zhang; Guochun Wang
Journal:  Arthritis Res Ther       Date:  2017-11-25       Impact factor: 5.156

9.  Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein.

Authors:  Yaqi Wang; Ting Wu; Danqing Hu; Xinxin Weng; Xiaojing Wang; Pei-Jer Chen; Xiaoping Luo; Hongwu Wang; Qin Ning
Journal:  J Lipid Res       Date:  2017-11-13       Impact factor: 5.922

Review 10.  Cholesterol metabolism and tumor.

Authors:  Ying Meng; Qifei Wang; Zhimin Lyu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.